Rebinding done by Spiralverse

Lord of Chaos: Book Six of 'The Wheel of Time' (Media tie-in) Spiral-Bound | December 11, 2012

Robert Jordan

★★★★☆+ from 50,001 + ratings

$25.28 - Free Shipping

The New York Times bestseller, available in trade paperback for the first time -- featuring new cover art

The Wheel of Time®, Robert Jordan's internationally bestselling fantasy series, has captured the imaginations of millions of readers worldwide. Now Lord of Chaos will be available in trade paperback for the first time. This new edition will feature cover art from award-winning artist Greg Manchess. This stunning cover art debuted on the e-book and will now grace bookstores for the first time on this handsome new edition.

Publisher: Macmillan
Original Binding: Trade Paperback
Pages: 960 pages
ISBN-10: 0765334658
Item Weight: 1.9 lbs
Dimensions: 6.1 x 1.7 x 9.2 inches
Customer Reviews: 4 out of 5 stars 50,001 + ratings
Jordan has come to dominate the world Tolkien began to reveal.

Robert Jordan was born in 1948 in Charleston, South Carolina. He taught himself to read when he was four with the incidental aid of a twelve-years-older brother, and was tackling Mark Twain and Jules Verne by five. He is a graduate of The Citadel, the Military College of South Carolina, with a degree in physics. He served two tours in Vietnam with the U.S. Army; among his decorations are the Distinguished Flying Cross with bronze oak leaf cluster, the Bronze Star with "V" and bronze oak leaf cluster, and two Vietnamese Gallantry Crosses with palm. A history buff, he has also written dance and theater criticism and enjoyed the outdoor sports of hunting, fishing, and sailing, and the indoor sports of poker, chess, pool, and pipe collecting.

Robert Jordan began writing in 1977 and went on to write The Wheel of Time®, one of the most important and best selling series in the history of fantasy publishing with over 14 million copies sold in North America, and countless more sold abroad.

Robert Jordan died on September 16, 2007, after a courageous battle with the rare blood disease amyloidosis.